Maky Zanganeh, Director at Pulse Biosciences, Inc. (PLSE), bought 87,520 shares at $20.84 ($1.8M) on 2017-05-11, disclosed to the SEC on 2017-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.16 | 33,760 | $681K | 38.2% |
| 2 | $20.16 | 33,760 | $681K | 38.2% |
| 3 | $21.71 | 5,000 | $109K | 6.1% |
| 4 | $20.84 | 15,000 | $313K | 17.5% |
| Total | $20.36 avg | 87,520 | $1.8M | 100% |
| Filing → |
| PLSE | BUY | 2020-06-25 | $13K | — | Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |